Dupont Capital Management’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,319
| Closed | -$151K | – | 517 |
|
|
2023
Q2 | $151K | Buy |
1,319
+821
| +165% | +$94K | 0.01% | 412 |
|
|
2023
Q1 | $68.6K | Sell |
498
-3,047
| -86% | -$420K | ﹤0.01% | 517 |
|
|
2022
Q4 | $459K | Sell |
3,545
-4,009
| -53% | -$519K | 0.02% | 588 |
|
|
2022
Q3 | $835K | Buy |
7,554
+3,114
| +70% | +$344K | 0.05% | 463 |
|
|
2022
Q2 | $333K | Buy |
+4,440
| New | +$333K | 0.02% | 839 |
|
|
2020
Q1 | – | Sell |
-4,169
| Closed | -$538K | – | 1370 |
|
|
2019
Q4 | $538K | Hold |
4,169
| – | – | 0.01% | 811 |
|
|
2019
Q3 | $314K | Sell |
4,169
-990
| -19% | -$74.6K | 0.01% | 976 |
|
|
2019
Q2 | $784K | Sell |
5,159
-2,082
| -29% | -$316K | 0.02% | 616 |
|
|
2019
Q1 | $863K | Buy |
7,241
+1,977
| +38% | +$236K | 0.02% | 589 |
|
|
2018
Q4 | $574K | Hold |
5,264
| – | – | 0.01% | 687 |
|
|
2018
Q3 | $850K | Buy |
5,264
+1,437
| +38% | +$232K | 0.02% | 604 |
|
|
2018
Q2 | $506K | Sell |
3,827
-1,836
| -32% | -$243K | 0.01% | 704 |
|
|
2018
Q1 | $420K | Sell |
5,663
-15,706
| -73% | -$1.16M | 0.01% | 703 |
|
|
2017
Q4 | $1.19M | Buy |
21,369
+8,647
| +68% | +$481K | 0.03% | 481 |
|
|
2017
Q3 | $577K | Buy |
12,722
+3,069
| +32% | +$139K | 0.01% | 642 |
|
|
2017
Q2 | $325K | Hold |
9,653
| – | – | 0.01% | 760 |
|
|
2017
Q1 | $286K | Sell |
9,653
-6,995
| -42% | -$207K | 0.01% | 789 |
|
|
2016
Q4 | $457K | Buy |
+16,648
| New | +$457K | 0.01% | 716 |
|
|
2014
Q4 | – | Sell |
-14,415
| Closed | -$304K | – | 642 |
|
|
2014
Q3 | $304K | Buy |
14,415
+2,380
| +20% | +$50.2K | 0.01% | 604 |
|
|
2014
Q2 | $359K | Buy |
+12,035
| New | +$359K | 0.01% | 603 |
|